by nikki mann | Dec 3, 2020 | News
As we reach the end of what has been the most challenging and difficult year so far, we want to take the time to celebrate the achievements of our Affiliated Companies. Despite challenging times there have been some fantastic updates, and you can explore them using...
by Alison Schuldt | Nov 25, 2020 | News
We are excited to announce that two new pharma partners — Eli Lilly and Company and Bristol Myers Squibb — have joined the Milner Consortium in the past month. Now with ten pharma partners and three academic partners, this has become one of the largest cross-sector...
by Alison Schuldt | Nov 16, 2020 | News
Start Codon, the life science and healthcare business accelerator based in the Milner Therapeutics Institute, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million. The Fund will be used to support Start Codon’s offering to start-ups,...
by Alison Schuldt | Nov 16, 2020 | News
Last month, the Translating Genomics in Oncology (TGIO) 2020 event was co-organized by two programmes of the CRUK Cambridge Centre – Early Detection and OncoInnovation – together with the University Enterprise Zone. The OncoInnovation programme is delivered in the...
by Alison Schuldt | Sep 10, 2020 | News
We are delighted to announce that Academic in Residence Kostas Tzelepis has been awarded a John Goldman Fellowship from Leukaemia UK to develop and characterize new drugs against the RNA methyltransferase METTL3, which he has previously uncovered as a relevant...
by Alison Schuldt | Jul 7, 2020 | News
We are delighted to announce that Kathryn Lilley, Director of the Cambridge Centre for Proteomics, is among 63 leading scientists who have been awarded EMBO membership today – elected on the basis of their scientific excellence and pioneering research. “The new...
